
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
Dec 30, 2025 02:39 am UTC| Business Health
Royalty Pharma Plc (NASDAQ: RPRX) shares rose 1.5% in after-hours trading on Monday after the company announced it had acquired the final portion of PTC Therapeutics remaining royalty interest in Evrysdi, a leading spinal...

Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio
Dec 25, 2025 02:04 am UTC| Business Health
French pharmaceutical giant Sanofi has announced plans to acquire U.S.-based biotech company Dynavax Technologies in a deal valued at approximately $2.2 billion (1.9 billion). The acquisition, agreed on Wednesday, is aimed...

GLP-1 Weight Loss Pills Set to Reshape Food and Fast-Food Industry in 2025
Dec 25, 2025 01:49 am UTC| Health Business
Packaged food manufacturers and fast-food restaurants are preparing for major shifts in consumer demand as appetite-suppressing GLP-1 weight loss pills are expected to enter the U.S. market in early 2025. Analysts believe...

Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
Dec 24, 2025 11:06 am UTC| Business Health
Sanofi has announced an agreement to acquire U.S.-based vaccines company Dynavax Technologies in an all-cash transaction valued at approximately $2.2 billion, marking another strategic move to expand its vaccines business....

FDA Approves Mitapivat for Anemia in Thalassemia Patients
Dec 24, 2025 05:24 am UTC| Governance Business Health
Agios Pharmaceuticals has announced a major regulatory milestone with the U.S. Food and Drug Administration approving mitapivat for the treatment of anemia in adults with alpha- or beta-thalassemia. The approval represents...

Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market
Dec 24, 2025 03:42 am UTC| Business Health
Global pharmaceutical leaders Eli Lilly and Novo Nordisk are intensifying competition in Indias rapidly expanding obesity drug market as they race to secure dominance before lower-cost generic alternatives arrive in early...

Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
Dec 23, 2025 01:57 am UTC| Business Health
Novo Nordisk A/S (NYSE: NVO) shares jumped nearly 8% in after-hours trading on Monday following a major regulatory milestone: the U.S. Food and Drug Administration approved the companys Wegovy pill, making it the first...